Vanguard Group Inc Dyadic International Inc Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Dyadic International Inc stock. As of the latest transaction made, Vanguard Group Inc holds 860,661 shares of DYAI stock, worth $903,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares

860,661

Previous 814,343 5.69%

Holding current value

$903,694

Previous $1.1 Million 22.47%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$0.92 - $1.4 $42,612 - $64,845	46,318 Added 5.69%	860,661 $852,000
Q1 2025 May 09, 2025	BUY	$1.32 - $1.96 $11,266 - $16,728	8,535 Added 1.06%	814,343 $1.1 Million
Q2 2024 Aug 13, 2024	BUY	$1.39 - $2.27 $2,460 - $4,017	1,770 Added 0.22%	805,808 $1.19 Million
Q1 2024 May 10, 2024	BUY	$1.29 - $1.67 $156 - $202	121 Added 0.02%	804,038 $1.34 Million
Q4 2023 Feb 14, 2024	BUY	$1.52 - $2.04 $31,924 - $42,846	21,003 Added 2.68%	803,917 $1.29 Million
Q3 2023 Nov 14, 2023	BUY	$1.71 - $2.08 $24,786 - $30,149	14,495 Added 1.89%	782,914 $1.5 Million
Q2 2023 Aug 14, 2023	BUY	$1.56 - $2.38 $20,173 - $30,778	12,932 Added 1.71%	768,419 $1.48 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $1.86 $1,891 - $2,814	1,513 Added 0.2%	755,487 $1.34 Million
Q4 2022 Feb 10, 2023	BUY	$1.18 - $2.32 $499 - $981	423 Added 0.06%	753,974 $927,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $5.34 $356,018 - $565,815	-105,958 Reduced 12.33%	753,551 $3.41 Million
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.49 $586,657 - $1.15 Million	-177,775 Reduced 17.14%	859,509 $4.78 Million
Q2 2021 Aug 13, 2021	BUY	$3.35 - $5.67 $3.47 Million - $5.88 Million	1,037,284 New	1,037,284 $3.72 Million

Others Institutions Holding DYAI

# of Institutions

Shares Held

5.07M

Call Options Held

49.6K

Put Options Held

View Full List

About DYADIC INTERNATIONAL INC

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $29.8M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

More about DYAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Dyadic International Inc Transaction History